Jan M. Kitzen

610 total citations
36 papers, 473 citations indexed

About

Jan M. Kitzen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Jan M. Kitzen has authored 36 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Jan M. Kitzen's work include Cardiac electrophysiology and arrhythmias (10 papers), Receptor Mechanisms and Signaling (7 papers) and Cardiac Arrhythmias and Treatments (4 papers). Jan M. Kitzen is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Receptor Mechanisms and Signaling (7 papers) and Cardiac Arrhythmias and Treatments (4 papers). Jan M. Kitzen collaborates with scholars based in United States, Canada and India. Jan M. Kitzen's co-authors include Benedict R. Lucchesi, Robert Taylor, Robert B. Raffa, Joseph V. Pergolizzi, Joseph J. Lynch, Judith K. Mickelson, Jonathon W. Homeister, Paul J. Simpson, Paul Hoff and Andrew C. G. Uprichard and has published in prestigious journals such as Circulation, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Jan M. Kitzen

33 papers receiving 431 citations

Peers

Countries citing papers authored by Jan M. Kitzen

Since Specialization

Citations

This map shows the geographic impact of Jan M. Kitzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan M. Kitzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan M. Kitzen more than expected).

Fields of papers citing papers by Jan M. Kitzen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan M. Kitzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan M. Kitzen. The network helps show where Jan M. Kitzen may publish in the future.

Co-authorship network of co-authors of Jan M. Kitzen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan M. Kitzen. A scholar is included among the top collaborators of Jan M. Kitzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan M. Kitzen. Jan M. Kitzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	E-Cigarette Survey among Student Pharmacists Reveals Troubling Results 2020 ·Pharmacology &amp Pharmacy ·(unknown), (unknown), Jan M. Kitzen, Joseph V. Pergolizzi, Robert Taylor, Robert B. Raffa	1
2	Crisaborole and Apremilast: PDE4 Inhibitors with Similar Mechanism of Action, Different Indications for Management of Inflammatory Skin Conditions 2018 ·Pharmacology &amp Pharmacy ·Jan M. Kitzen, Joseph V. Pergolizzi, Robert Taylor, Robert B. Raffa	10
3	Sunscreen bans: Coral reefs and skin cancer 2018 ·Journal of Clinical Pharmacy and Therapeutics ·Robert B. Raffa, Joseph V. Pergolizzi, Robert Taylor, Jan M. Kitzen	75
4	Cardiovascular Pharmacology of the Adenosine A1/A2-Receptor Agonist AMP 579: Coronary Hemodynamic and Cardioprotective Effects in the Canine Myocardium 1999 ·Journal of Cardiovascular Pharmacology ·Matthew J. McVey, Glenn J. Smits, Bryan F. Cox, Jan M. Kitzen, Kenneth L. Clark, Mark H. Perrone	32
5	Potassium Channel Activators Cromakalim and Celikalim (WAY-120,491) Fail to Decrease Myocardial Infarct Size in the Anesthetized Canine 1992 ·Pharmacology ·Jan M. Kitzen, J. McCallum, (unknown), (unknown), (unknown), Thomas Colatsky	19
6	Class III antiarrhythmic activity of novel substituted 4-[(methylsulfonyl)amino]benzamides and sulfonamides 1992 ·Journal of Medicinal Chemistry ·John W. Ellingboe, Walter Spinelli, (unknown), Thomas T. Nguyen, (unknown), (unknown), Jan M. Kitzen, (unknown), Jehan F. Bagli	49
7	New modified heterocyclic phenylalanine derivatives. Incorporation into potent inhibitors of human renin 1992 ·Journal of Medicinal Chemistry ·Timothy D. Ocain, David D. Deininger, (unknown), (unknown), Alan H. Katz, Jan M. Kitzen, Robert A. Mitchell, (unknown), Anthony J. Russo	5
8	Antithrombotic Activity of the Phosphodiesterase III Inhibitor Pelrinone in a Canine Model of Coronary Artery Thrombosis 1991 ·Journal of Cardiovascular Pharmacology ·Jan M. Kitzen, J. McCallum, (unknown), (unknown)	0
9	Hypothyroidism Renders Protection Against Lethal Ventricular Arrhythmias in a Conscious Canine Model of Sudden Death 1991 ·Journal of Cardiovascular Pharmacology ·Nagammal Venkatesh, Joseph J. Lynch, Andrew C. G. Uprichard, Jan M. Kitzen, Bramah N. Singh, Benedict R. Lucchesi	16
10	Potentiation of phosphodiesterase inhibitor antithrombotic activity with alpha-2 adrenergic blockade 1991 ·Life Sciences ·Jan M. Kitzen, J. McCallum, (unknown), Thomas Colatsky	4
11	Effects of Combined Thromboxane Synthetase Inhibition/Thromboxane Receptor Antagonism in Two Models of Sudden Cardiac Death in the Canine: Limited Role for Thromboxane 1990 ·Journal of Cardiovascular Pharmacology ·Jan M. Kitzen, Liguo Chi, Andrew C. G. Uprichard, Benedict R. Lucchesi	4
12	Effects of the Positive Inotropic Agents Milrinone and Pimobendan on the Development of Lethal Ischemic Arrhythmias in Conscious Dogs with Recent Myocardial Infarction 1989 ·Journal of Cardiovascular Pharmacology ·Joseph J. Lynch, Andrew C. G. Uprichard, John Frye, Edward M. Driscoll, Jan M. Kitzen, Benedict R. Lucchesi	21
13	Effects of Pimobendan (UD-CG 115 BS), a New Positive Inotropic Agent, on Ventricular Tachycardia and Ischemic Ventricular Fibrillation in a Conscious Canine Model of Recent Myocardial Infarction 1988 ·Journal of Cardiovascular Pharmacology ·Joseph J. Lynch, Jan M. Kitzen, Paul Hoff, Benedict R. Lucchesi	26
14	The Mechanism for the Clonidine-Induced Coronary Artery Dilatation in the Canine Heart 1988 ·Journal of Cardiovascular Pharmacology ·(unknown), Martin M. Winbury, Jan M. Kitzen, (unknown), Benedict R. Lucchesi	6
15	Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Jan M. Kitzen, Joseph J. Lynch, Edward M. Driscoll, B R Lucchesi	17
16	[(6,7-Dichlorobenzo[b]thien-5-yl)oxy]acetic acids and 1,1-dioxides. 1. A structurally novel class of diuretics with hypotensive activity 1987 ·Journal of Medicinal Chemistry ·Helen H. Ong, Steven R. Caldwell, James A. Profitt, (unknown), (unknown), Jeffrey C. Wilker, (unknown), Jan M. Kitzen	3
17	ChemInform Abstract: 2,3‐DIHYDRO‐3‐(1‐PYRRYL)SPIRO(BENZOFURAN‐2,4′‐PIPERIDINE)S AND 2,3‐DIHYDRO‐3‐(1‐PYRRYL)SPIRO(BENZOFURAN‐2,3′‐PYRROLIDINE)S: NOVEL ANTIHYPERTENSIVE AGENTS 1984 ·Chemischer Informationsdienst ·Larry D. Davis, (unknown), (unknown), Joseph Klein, Jan M. Kitzen, (unknown)	1
18	2,3-Dihydro-3-(1-pyrryl)spiro[benzofuran-2,4'-piperidine]s and 2,3-dihydro-3-(1-pyrryl)spiro[benzofuran-2,3'-pyrrolidine]s: novel antihypertensive agents 1983 ·Journal of Medicinal Chemistry ·Larry D. Davis, (unknown), (unknown), Joseph Klein, Jan M. Kitzen, (unknown)	9
19	Effects of N⁶‐cyclohexyladenosine (CHA) on responses to adrenergic and cholinergic nerve stimulation in the peripheral autonomic nervous system 1983 ·Drug Development Research ·Jan M. Kitzen, (unknown), (unknown), (unknown), Sandy J. Wilson	1
20	Vasodilator Activity of Adenosine Analogs 1978 ·Journal of Pharmaceutical Sciences ·Aleem Gangjee, Harry P. C. Hogenkamp, Jan M. Kitzen	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact